ICCC NASDAQ
ImmuCell Corporation
1W: -1.8%
1M: -2.5%
3M: -3.1%
YTD: +64.7%
1Y: +47.7%
3Y: +80.6%
5Y: -0.1%
$9.75
+0.15 (+1.56%)
Weekly Expected Move ±3.1%
$9
$9
$10
$10
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$31M
Revenue
+8.5% YoY
$1M
Net Income
-55.3% YoY
$4M
Free Cash Flow
+138.9% YoY
33.9%
Gross Margin
26.9%
Op. Margin
25.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE2.6%
ROA1.7%
ROIC10.2%
Valuation
P/E115.2
P/B2.8
EV/EBITDA27.1
Leverage
Debt/Equity0.40
Current Ratio4.75
Interest Cov.2.7x
Quality Scores
Piotroski F6/9
Altman Z4.46
Beneish M-2.84